Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Sep;42(3):385–391. doi: 10.1038/bjc.1980.249

Failure to detect autologous antibodies in the remission sera of patients with AML: complications introduced by the presence of rheumatoid factor.

S E James, C J Dean, P Alexander
PMCID: PMC2010419  PMID: 6932909

Abstract

Sera were collected from patients with acute myelogenous leukaemia (AML) at various times during remission induced by chemotherapy, but after cessation of all immunosupressive treatment. These sera were tested, by a sensitive assay using radio-labelled antiglobulin binding, for the presence of antibodies which bound to the surface of autologous AML cells. The cell populations examined were chosen on the basis that they proliferated in short-term culture, did not bind anti-Ig reagents directly, and that more than 80% of the cells did not carry detectable Fc receptors. With 8/9 patients studied, no specific antibodies of the IgG or IgM class could be detected in serum samples taken during remission. IgG and IgM antibodies from the remission sera of one patient were found be bind to autologous leukaemic cells, but this was found to be due to the presence of rheumatoid factor (RF) and removal of the RF activity abolished this binding. This study has, like others, failed to detect autologous antibodies, in remission sera, that are directed against membrane components of AML cells.

Full text

PDF
385

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergholtz B., Albrechtsen D., Thorsby E. Stimulation of T lymphocytes by autologous non-T lymphoid cells. Participation of HLA-D? Tissue Antigens. 1977 Jul;10(1):27–38. doi: 10.1111/j.1399-0039.1977.tb00748.x. [DOI] [PubMed] [Google Scholar]
  2. Chapuis B. J., Powles R., Alexander P. Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy. Clin Exp Immunol. 1978 May;32(2):253–258. [PMC free article] [PubMed] [Google Scholar]
  3. Chapuis B., Summersgill B. M., Cocks P., Howard P., Lawler S. D., Alexander P., Powles R. Test for cryopreservation efficiency of human acute myelogenous leukaemia cells relevant to clinical requirements. Cryobiology. 1977 Dec;14(6):637–648. doi: 10.1016/0011-2240(77)90018-9. [DOI] [PubMed] [Google Scholar]
  4. Cocks P., Powles R. L., Chapuis B., Alexander P. Further evidence of response by leukaemia patients in remission to antigen(s) related to acute myelogenous leukaemia. Br J Cancer. 1977 Mar;35(3):273–279. doi: 10.1038/bjc.1977.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fridman W. H., Kourilsky F. M. Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia. Nature. 1969 Oct 18;224(5216):277–279. doi: 10.1038/224277a0. [DOI] [PubMed] [Google Scholar]
  6. Gale D. G., MacLennan I. C. Cytotoxic antibody in acute myeloblastic leukaemia during immunotherapy: lack of tumour specificity. Br J Cancer. 1977 Mar;35(3):280–287. doi: 10.1038/bjc.1977.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Giuliano A. E., Irie R., Morton D. L. Rheumatoid factor in melanoma patients: alterations of humoral tumor immunity in vitro. Cancer. 1979 May;43(5):1624–1629. doi: 10.1002/1097-0142(197905)43:5<1624::aid-cncr2820430510>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  8. Henle G., Lennette E. T., Alspaugh M. A., Henle W. Rheumatoid factor as a cause of positive reactions in tests for Epstein-Barr virus-specific IgM antibodies. Clin Exp Immunol. 1979 Jun;36(3):415–422. [PMC free article] [PubMed] [Google Scholar]
  9. McConahey P. J., Dixon F. J. A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol. 1966;29(2):185–189. doi: 10.1159/000229699. [DOI] [PubMed] [Google Scholar]
  10. Opelz G., Kiuchi M., Takasugi M., Terasaki P. I. Autologous stimulation of human lymphocyte subpopulation. J Exp Med. 1975 Nov 1;142(5):1327–1333. doi: 10.1084/jem.142.5.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Palú G., Powles R., Selby P., Summersgill B. M., Alexander P. Patterns of maturation in short-term culture of human acute myeloid leukaemic cells. Br J Cancer. 1979 Nov;40(5):719–730. doi: 10.1038/bjc.1979.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Powles R. Immunotherapy for acute myelogenous leukaemia. Br J Cancer Suppl. 1973 Aug;1:262–265. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES